Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisatracurium besilate dose-finding study in orthopedic surgery
ChiCTR1900025301Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cisatracurium (4 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Blood drug concentration. Planned start Sep 2016; status: not yet recruiting.
02
Drugs
cisatracurium
Beyond the preview
Go deeper on ChiCTR1900025301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025301.